197 related articles for article (PubMed ID: 24714693)
1. Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men.
Swedish KA; Goldstone SE
PLoS One; 2014; 9(4):e93393. PubMed ID: 24714693
[TBL] [Abstract][Full Text] [Related]
2. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study.
Swedish KA; Factor SH; Goldstone SE
Clin Infect Dis; 2012 Apr; 54(7):891-8. PubMed ID: 22291111
[TBL] [Abstract][Full Text] [Related]
3. Clinical Inquiry: Does qHPV vaccine prevent anal intraepithelial neoplasia and condylomata in men?
Shum J; Kelsberg G; Safranek S
J Fam Pract; 2015 Sep; 64(9):581-3. PubMed ID: 26546954
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
[TBL] [Abstract][Full Text] [Related]
5. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
Herweijer E; Leval A; Ploner A; Eloranta S; Simard JF; Dillner J; Netterlid E; Sparén P; Arnheim-Dahlström L
JAMA; 2014 Feb; 311(6):597-603. PubMed ID: 24519299
[TBL] [Abstract][Full Text] [Related]
6. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia.
Palefsky JM; Giuliano AR; Goldstone S; Moreira ED; Aranda C; Jessen H; Hillman R; Ferris D; Coutlee F; Stoler MH; Marshall JB; Radley D; Vuocolo S; Haupt RM; Guris D; Garner EI
N Engl J Med; 2011 Oct; 365(17):1576-85. PubMed ID: 22029979
[TBL] [Abstract][Full Text] [Related]
7. Timing of two versus three doses of quadrivalent HPV vaccine and associated effectiveness against condyloma in Sweden: a nationwide cohort study.
Lamb F; Herweijer E; Ploner A; Uhnoo I; Sundström K; Sparén P; Arnheim-Dahlström L
BMJ Open; 2017 Jun; 7(6):e015021. PubMed ID: 28600369
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness and cost-effectiveness of quadrivalent human papillomavirus vaccination in HIV-negative men who have sex with men to prevent recurrent high-grade anal intraepithelial neoplasia.
Deshmukh AA; Chiao EY; Das P; Cantor SB
Vaccine; 2014 Dec; 32(51):6941-6947. PubMed ID: 25444820
[TBL] [Abstract][Full Text] [Related]
9. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis.
Kim JJ
Lancet Infect Dis; 2010 Dec; 10(12):845-52. PubMed ID: 21051295
[TBL] [Abstract][Full Text] [Related]
10. Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men-United States, 2016-2018.
Meites E; Winer RL; Newcomb ME; Gorbach PM; Querec TD; Rudd J; Collins T; Lin J; Moore J; Remble T; Swanson F; Franz J; Bolan RK; Golden MR; Mustanski B; Crosby RA; Unger ER; Markowitz LE
J Infect Dis; 2020 Nov; 222(12):2052-2060. PubMed ID: 32504091
[TBL] [Abstract][Full Text] [Related]
11. Anal condyloma acuminatum.
McCutcheon T
Gastroenterol Nurs; 2009; 32(5):342-9. PubMed ID: 19820442
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
Dominiak-Felden G; Gobbo C; Simondon F
PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Human Papillomavirus Genotype in Anal Condyloma Acuminatum Among Japanese Men: The Higher Prevalence of High Risk Human Papillomavirus in Men Who Have Sex with Men with HIV Infection.
Furukawa S; Uota S; Yamana T; Sahara R; Iihara K; Yokomaku Y; Iwatani Y; Sugiura W
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):375-381. PubMed ID: 29183133
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of human papillomavirus vaccination strategies among men who have sex with men in China: a modeling study.
Li Y; Lin YF; Wu X; Zhou X; Tian T; Guo Z; Fu L; Yang L; Lu Z; Fan S; Lu Y; Ke W; Zou H
Front Immunol; 2023; 14():1197191. PubMed ID: 37426648
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Outcomes of Adding HPV Vaccine to the Anal Intraepithelial Neoplasia Treatment Regimen in HIV-Positive Men Who Have Sex With Men.
Deshmukh AA; Chhatwal J; Chiao EY; Nyitray AG; Das P; Cantor SB
Clin Infect Dis; 2015 Nov; 61(10):1527-35. PubMed ID: 26223993
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
[TBL] [Abstract][Full Text] [Related]
17. Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study.
Leval A; Herweijer E; Ploner A; Eloranta S; Fridman Simard J; Dillner J; Young C; Netterlid E; Sparén P; Arnheim-Dahlström L
J Natl Cancer Inst; 2013 Apr; 105(7):469-74. PubMed ID: 23486550
[TBL] [Abstract][Full Text] [Related]
18. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
Cocchio S; Prandi GM; Furlan P; Bertoncello C; Fonzo M; Saia M; Baldovin T; Baldo V
BMC Infect Dis; 2020 Nov; 20(1):857. PubMed ID: 33208109
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-preventable anal infections by human papillomavirus among HIV-infected men who have sex with men.
Giuliani M; Latini A; Colafigli M; Benevolo M; Rollo F; Zaccarelli M; Giuliani E; Moretto D; Giglio A; Rezza G; Cristaudo A; Donà MG
Future Microbiol; 2018 Oct; 13():1463-1472. PubMed ID: 30311788
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.
Hillman RJ; Giuliano AR; Palefsky JM; Goldstone S; Moreira ED; Vardas E; Aranda C; Jessen H; Ferris DG; Coutlee F; Marshall JB; Vuocolo S; Haupt RM; Guris D; Garner EI
Clin Vaccine Immunol; 2012 Feb; 19(2):261-7. PubMed ID: 22155768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
